Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Saturday, June 24, 2017 12:48:40 PM
HHSE/CRIM/Newco MERGER. Exciting times for HHSE investors. HHSE has increased from about .005 to .027. Only the beginning.
I sat down and quickly gathered 11 reasons why HHSE/CRIM/Newco stock continues to rise post MERGER.
Pre MERGER ad nauseam this board has documented HHSE fair and true price is north of .10. After doing simple Due Diligence is very easy to see the imminent Post MERGER increases the value of HHSE conservatively to .20 to .30 or greater. A 700% to 1,000% Increase of Return from here.
Every other day I will try to post here and discuss, provide further details to each of the 11 reasons. Until then, a quick list so that one may conduct proper Due Diligence. The information is all there and available for the shrewd investor..
11 Reasons HHSE/CRIM/Newco Stock Continues Increasing Post MERGER
1.) Multiple Legal Issue Settlements
2.) Launch VODwiz
3.) Increased Revenues / Earnings. HHSE/CRIM Visibility, Stature, Valuation
4.) NASDAQ Uplist. Sophisticated, informed investors. Additionally, Asian (Chinese) based investors
5.) Artificial Manipulation, Stock Price Boxing Completion/Exhausted
6.) 5 Significant Media Players (Chinese Based) Conduct Various Post MERGER Financial Transactions ($65,000,000 Funding)
7.) $4,000,000 HHSE/CRIM/Newco Direct Stock Purchase @ 100% Premium (Major Media Company)
8.) HHSE/CRIM/Newco Share Support. Contemporaneous with the merger, several of the China-based affiliates will be buying blocks of Crimson stock on the public markets
Additionally, Post MERGER HHSE/CRIM Embark on three, very exciting new distribution ventures that post merger activities will have a dramatic impact on the company's revenues, visibility and valuation, involving:
9.) North American Activities
10.) International Sales
11.) Theatrical Distribution In China
http://crimsonforestentertainment.com/our-team/
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM